Comorbid depression and ADHD in children and adolescents: Consensus and controversy

Psychiatric Times

Volumn 25, Issue 10, 2008, Pages 13-17

  Brunsvold, Gavin L ^a   Oepen, Godehard ^a   Federman, Edward J ^b   Akins, Richard ^a  

^a Alabama Psychiatric Services   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 53849113685     PISSN: 08932905     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Kessler RC, Adler LA, Barkley R, et al. Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: results from the national comorbidity survey replication. Biol Psychiatry. 2005; 57:1442-1451.
2. Thakkar V, Adler L. Depression and ADHD: what you need to know. MedScape. http://www.medscape.com/viewarticle/549018_print. Accessed August 13, 2008.
3. Furman L. What is attention-deficit hyperactivity disorder (ADHD)? J Child Neurol. 2005;20:994-1002.
4. Angold A, Costello EJ, Erkanli A. Comorbidity. J Child Psychol Psychiatry. 1999;40:57-87.
5. Luby JL, Heffelfinger AK, Mrakotsky C, et al. The clinical picture of depression in preschool children. J Am Acad Child Adolesc Psychiatry. 2003;42:340-348.
6. Alston JF. The complex issue of attachment disorders. Psychiatric Times. October 1, 2007. http://www.psychiatrictimes.com/display/article/ 10168/54326. Accessed August 13, 2008.
7. Compton SN, March JS, Brent D, et al. Cognitive-behavioral psychotherapy for anxiety and depressive disorders in children and adolescents: an evidence-based medicine review. J Am Acad Child Adolesc Psychiatry. 2004;43:930-959.
8. Pliszka SR, Crismon ML, Hughes CW, et al. The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2006;45:642-657.
9. Rostain AL. Treatment resistance in youths with ADHD and comorbid conditions. Psychiatric Times. October 1, 2007. http://www. psychiatrictimes.com/display/article/10168/54501. Accessed August 13, 2008.
10. Crystal DS, Ostrander R, Chen RS, August GJ. Multimethod assessment of psychopathology among DSM-IV subtypes of children with attention-deficit/ hyperactivity disorder: self-, parent, and teacher reports. J Abnorm Child Psychol. 2001;29:189-205.
11. Faraone SV, Biederman J, Monuteaux MC. Attention-deficit disorder and conduct disorder in girls: evidence for a familial subtype. Biol Psychiatry. 2000; 48:21-29.
12. Jensen PS, Hinshaw SP, Kraemer HC, et al. ADHD comorbidity findings from the MTA study: comparing comorbid subgroups. J Am Acad Child Adolesc Psychiatry. 2001;40:147-158.
13. Faraone SV. Genetics of childhood disorders: XX. ADHD, Part 4: is ADHD genetically heterogeneous? J Am Acad Child Adolesc Psychiatry. 2000;39:1455-1457.
14. Faraone SV, Biederman J, Feighner JA, Monuteaux MC. Assessing symptoms of attention deficit hyperactivity disorder in children and adults: which is more valid? J Consult Clin Psychol. 2000;68:830-842.
15. Ryan ND. Diagnosing pediatric depression. Biol Psychiatry. 2001;49:1050-1054.
16. Swanson JM, Kraemer HC, Hinshaw SP, et al. Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment. J Am Acad Child Adolesc Psychiatry. 2001;40:168-179.
17. Marmorstein NR. Relationships between anxiety and externalizing disorders in youth: the influences of age and gender. J Anxiety Disord. 2007;21:420-432.
18. Sanders M, Arduca Y, Karamitsios M, et al. Characteristics of internalizing and externalizing disorders in medication-naive, clinically referred children with attention deficit hyperactivity disorder, combined type and dysthymic disorder. Aust N Z J Psychiatry. 2005; 39:359-365.
19. Oepen G, Federman EJ, Akins R. Measuring outcome in psychiatric private practice using outpatient self-reports. Psychiatric Times. June 1, 2006. http://www.psychiatrictimes.com/display/article/10168/51451. Accessed August 13, 2008.
20. Blackman GL, Ostrander R, Herman KC. Children with ADHD and depression: a multisource, multimethod assessment of clinical, social, and academic functioning. J Atten Disord. 2005;8:195-207.
21. Mick E, Biederman J, Santangelo S, Wypij D. The influence of gender in the familial association between ADHD and major depression. J Nerv Ment Dis. 2003;191:699-705.
22. Biederman J, Mick E, Faraone SV, et al. Influence of gender on attention deficit hyperactivity disorder in children referred to a psychiatric clinic. Am J Psychiatry. 2002;159:36-42.
23. Ostrander R, Crystal DS, August G. Attention deficit-hyperactivity disorder, depression, and self-and other-assessments of social competence: a developmental study. J Abnorm Child Psychol. 2006;34:773-787.
24. Biederman J, Monuteaux MC, Mick E, et al. Young adult outcome of attention deficit hyperactivity disorder: a controlled 10-year follow-up study. Psychol Med. 2006;36:167-179.
25. MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children With ADHD. Arch Gen Psychiatry. 1999;56:1073-1086.
26. Doss AJ, Weisz JR. Syndrome co-occurrence and treatment outcomes in youth mental health clinics. J Consult Clin Psychol. 2006;74:416-425.
27. Jensen PS, Martin D, Cantwell DP. Comorbidity in ADHD: implications for research, practice, and DSM-V. J Am Acad Child Adolesc Psychiatry. 1997;36:1065-1079.
28. Jensen PS, Hinshaw SP, Kraemer HC, et al. Introduction: ADHD comorbidity and treatment outcomes in the MTA. J Am Acad Child Adolesc Psychiatry. 2001;40:134-136.
29. Kazdin AE, Whitley MK. Comorbidity, case complexity, and effects of evidence-based treatment for children referred for disruptive behavior. J Consult Clin Psychol. 2006;74:455-467.
30. Diler R, Daviss W, Birmaher B, et al. Differentiating major depressive disorder in youths with ADHD. Paper presented at: University of Pittsburgh Medical Center, Seventh Annual Research Day; June 2007.
31. Barrickman LL, Perry PJ, Allen AJ, et al. Bupropion versus methylphenidate in the treatment of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 1995;34:649-657.
32. Solhkhah R, Wilens TE, Daly J, et al. Bupropion SR for the treatment of substance-abusing outpatient adolescents with attention-deficit/hyperactivity disorder and mood disorders. J Child Adolesc Psychopharmacol. 2005;15:777-786.
33. Findling RL. Open-label treatment of comorbid depression and attentional disorders with co-administration of serotonin reuptake inhibitors and psychostimulants in children, adolescents, and adults: a case series. J Child Adolesc Psychopharmacol. 1996;6: 165-175.
34. Bangs ME, Emslie GJ, Spencer TJ; Atomoxetine ADHD and Comorbid MDD Study Group, et al. Efficacy and safety of atomoxetine in adolescents with attention-deficit/hyperactivity disorder and major depression. J Child Adolesc Psychopharmacol. 2007;17: 407-420.
35. Scheffer RE. Concurrent ADHD and bipolar disorder. Curr Psychiatry Rep. 2007;9:415-419.
36. Goodwin FK, Jamison KR. Diagnosis. In: Goodwin FK, Jamison KR. Manic-Depressive Illness. 2nd ed. New York: Oxford University Press; 2007:89-118.
37. Ostrander R, Crystal DS, August G. Attention deficit-hyperactivity disorder, depression, and self- and other-assessments of social competence: a developmental study. J Abnorm Child Psychol. 2006;34:773-787.
38. Swanson JM, Kraemer HC, Hinshaw SP, et al. Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment. J Am Acad Child Adolesc Psychiatry. 2001;40:168-179.